Additionally, androgen receptor binds to the −187 to −2000 promoter region of CAND1. Collectively, CAND1 mitigates NAFLD by inhibiting Cullin1/FBXO42 mediated ACAA2 degradation. This evidence concerns the gene AR and metabolic dysfunction-associated steatotic liver disease.